{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:37:11Z","timestamp":1761745031001},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1684\/bdc.2011.1302","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T19:58:33Z","timestamp":1565726313000},"page":"113-119","source":"Crossref","is-referenced-by-count":4,"title":["Inefficacit\u00e9 du d\u00e9pistage des cancers tubo-ovariens dans les situations de risque h\u00e9r\u00e9ditaire de cancer de l\u2019ovaire ; l\u2019exp\u00e9rience du Centre Oscar-Lambret"],"prefix":"10.1016","volume":"98","author":[{"given":"Sophie","family":"Ta\u00efeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Rocourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Narducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Adenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Doutrelant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Peyrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Vennin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2011.1302_bib0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJMcp0901926","article-title":"Screening for ovarian cancer","volume":"361","author":"Clarke-Pearson","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2011.1302_bib0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1684\/bdc.2011.1302_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/AOG.0b013e31819cda77","article-title":"Results from four rounds of ovarian cancer screening in a randomized trial","volume":"113","author":"Partridge","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1684\/bdc.2011.1302_bib0020","first-page":"219","article-title":"Identification et prise en charge des pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers du sein et de l\u2019ovaire","volume":"91","author":"Eisinger","year":"2004","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1302_bib0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/ijgc-00009577-200201000-00014","article-title":"Use of CA 125 and ultrasound in high-risk women","volume":"12","author":"Laframboise","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1684\/bdc.2011.1302_bib0030","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1006\/gyno.2000.5816","article-title":"The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer","volume":"77","author":"Van Nagell","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2011.1302_bib0035","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","article-title":"Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers","volume":"20","author":"Scheuer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1302_bib0040","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","article-title":"Use of proteomic patterns in serum to identify ovarian cancer","volume":"359","author":"Petricoin","year":"2002","journal-title":"Lancet"},{"key":"10.1684\/bdc.2011.1302_bib0045","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.bjc.6603015","article-title":"Surveillance of women at high risk for hereditary ovarian cancer is inefficient","volume":"94","author":"Oei","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2011.1302_bib0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ijc.24038","article-title":"Time to stop ovarian cancer screening in BRCA1\/2 mutation carriers?","volume":"124","author":"Van der Velde","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1684\/bdc.2011.1302_bib0055","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":"No efficacy of annual gynaecological screening in BRCA1\/2 mutation carriers; an observational follow-up study","volume":"96","author":"Hermsen","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2011.1302_bib0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.2006.07.4922","article-title":"Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1\/2 mutaion carriers","volume":"25","author":"Madalinska","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1302_bib0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/GIM.0b013e3181f48d1c","article-title":"Time to prophylactic surgery in BRCA1\/2 carriers depends on sociodemographic, familial, and psychological characteristics","volume":"12","author":"Julian-Reynier","year":"2010","journal-title":"Genet Med"},{"key":"10.1684\/bdc.2011.1302_bib0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bjc.6604830","article-title":"Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation","volume":"100","author":"Metcalfe","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2011.1302_bib0075","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1158\/1078-0432.CCR-08-0112","article-title":"High risk for ovarian cancer in a prospective series is restricted to BRCA1\/2 mutations carriers","volume":"14","author":"Maehle","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1684\/bdc.2011.1302_bib0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","article-title":"Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers","volume":"28","author":"Kurian","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1302_bib0085","unstructured":"http:\/\/www.e-cancer.fr\/"},{"key":"10.1684\/bdc.2011.1302_bib0090","doi-asserted-by":"crossref","first-page":"206s","DOI":"10.1200\/JCO.2003.02.955","article-title":"Calculation of the risk of ovarian cancer from serial CA-values for preclinical detection in postmenopausal women","volume":"21","author":"Skates","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1302_bib0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jnci\/djp438","article-title":"Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study","volume":"102","author":"Anderson","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2011.1302_bib0100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preffered site for early adenocarcinoma in women with familial ovarian cancer syndorme","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1684\/bdc.2011.1302_bib0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurmann","year":"2010","journal-title":"Am J Surg Pathol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115306792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115306792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:42:55Z","timestamp":1602492175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115306792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0007455115306792"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2011.1302","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}